🇺🇸 FDA
Pipeline program

Pegyinterferon-alfa-2a

ML28486

Approved small_molecule completed

Quick answer

Pegyinterferon-alfa-2a for Chronic Hepaititis B is a Approved program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Chinese University of Hong Kong
Indication
Chronic Hepaititis B
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials